Studies involving disease:Fatty liver disease

Study ID Study Title Species Institute
ST000194Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitisMouseUniversity of Michigan
ST000254The role of microbial metabolites in experimental liver diseaseMouseUniversity of North Carolina
ST000665Nonalcoholic fatty liver disease (NAFLD) StudiesHumanUniversity of Michigan
ST000677Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrationsHumanUniversity of Michigan
ST000678Functional genomics study on Non Alcoholic fatty liver disease (NAFLD)HumanUniversity of Michigan
ST000679Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part IIHumanUniversity of Michigan
ST000680Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part IIIHumanUniversity of Michigan
ST000693Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II)MouseUniversity of Michigan
ST000779Lipidomics pilot project for mice exposure to bisphenol A and high fat dietsMouseUniversity of Michigan
ST000915Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 1:LiverHumanLIPID MAPS
ST000916Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:PlasmaHumanLIPID MAPS
ST000917Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:UrineHumanLIPID MAPS
ST000977Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD)HumanUniversity of California, Davis
ST000993Tibetan medicine Shi-Wei-Gan-Ning-Pill (SWGNP) protect rats from ccl4 induced liver fibrosis.(Part I: Liver)RatNanjing University of Science & Technology
ST000994Tibetan medicine Shi-Wei-Gan-Ning-Pill (SWGNP) protect rats from ccl4 induced liver fibrosis (Part II: Serum)RatNanjing University of Science & Technology
ST001185Genetic and metabolic characterization of bioengineered human fatty liver tissue with modified SIRT1 expressionHumanUniversity of Pittsburgh
ST001428Role of environmental toxicants in modulating disease severity in children with NAFLDHumanEmory University
ST001680Metabolome of NAFLD in high fat diet mouse modelMouseWeill Cornell Medicine
ST001710Metabolic signatures of NAFLD - Lipidomics data (part 1 of 3)HumanÖrebro University
ST001711Metabolic signatures of NAFLD - Polar metabolomics data (part II)HumanÖrebro University
ST001842Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part I)HumanUniversity of California, Davis
ST001843Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II)HumanUniversity of California, Davis
ST001844Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III)HumanUniversity of California, Davis
ST001845Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part V)HumanUniversity of California, Davis
ST001919Exposure to environmental contaminants is associated with alterations in hepatic lipid metabolism in non-alcoholic fatty liver diseaseMouseÖrebro University
ST001964Quantitative genome-scale analysis of human liver reveals dysregulation of glycosphingolipid pathways in progressive nonalcoholic fatty liver diseaseHumanUniversity of Turku
ST002091Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in MexicoHumanUniversity of California, Los Angeles
ST002156Mouse liver metabolitesMouseUniversity of Missouri-Columbia

Return to search page
  logo